Credit Suisse Ag Sorrento Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.74 - $1.83 $462,492 - $1.14 Million	-624,990 Reduced 60.89%	401,484 $357,000
Q3 2022 Nov 10, 2022	BUY	$1.51 - $2.88 $1.12 Million - $2.14 Million	741,671 Added 260.42%	1,026,474 $1.61 Million
Q2 2022 Aug 12, 2022	SELL	$1.24 - $2.33 $271 - $510	-219 Reduced 0.08%	284,803 $573,000
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $28,538 - $69,918	14,269 Added 5.27%	285,022 $664,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $49,108 - $76,356	-10,561 Reduced 3.75%	270,753 $1.26 Million
Q3 2021 Nov 12, 2021	SELL	$7.41 - $10.99 $753,515 - $1.12 Million	-101,689 Reduced 26.55%	281,314 $2.15 Million
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $1.21 Million - $1.91 Million	190,582 Added 99.04%	383,003 $3.71 Million
Q1 2021 May 14, 2021	SELL	$7.03 - $16.51 $1.84 Million - $4.32 Million	-261,431 Reduced 57.6%	192,421 $1.59 Million
Q4 2020 Feb 12, 2021	BUY	$5.76 - $11.95 $293,264 - $608,422	50,914 Added 12.64%	453,852 $3.1 Million
Q3 2020 Nov 13, 2020	SELL	$6.17 - $18.82 $123,578 - $376,945	-20,029 Reduced 4.74%	402,938 $4.49 Million
Q2 2020 Aug 12, 2020	BUY	$1.73 - $6.76 $731,732 - $2.86 Million	422,967 New	422,967 $2.66 Million
Q1 2020 May 13, 2020	SELL	$1.57 - $4.76 $213,487 - $647,260	-135,979 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$1.45 - $4.17 $88,132 - $253,456	60,781 Added 80.83%	135,979 $459,000
Q3 2019 Nov 12, 2019	BUY	$2.05 - $2.69 $7,519 - $9,866	3,668 Added 5.13%	75,198 $161,000
Q2 2019 Aug 14, 2019	SELL	$2.67 - $4.38 $14,279 - $23,424	-5,348 Reduced 6.96%	71,530 $191,000
Q1 2019 May 14, 2019	BUY	$1.86 - $5.94 $18,523 - $59,156	9,959 Added 14.88%	76,878 $364,000
Q4 2018 Feb 13, 2019	BUY	$2.01 - $4.24 $7,625 - $16,086	3,794 Added 6.01%	66,919 $160,000
Q3 2018 Nov 13, 2018	SELL	$4.22 - $7.5 $43,904 - $78,030	-10,404 Reduced 14.15%	63,125 $278,000
Q2 2018 Aug 14, 2018	BUY	$4.75 - $8.0 $349,262 - $588,232	73,529 New	73,529 $529,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account